Liver microsomal flavin-containing monooxygenases (FMO, EC 1.14.13.8) 1 and 3 were functionally characterized in terms of expression levels and molecular catalytic capacities in human, cynomolgus monkey, rat, and minipig livers. Liver microsomal FMO3 in humans and monkeys and FMO1 and FMO3 in rats and minipigs could be determined immunochemically with commercially available anti-human FMO3 peptide antibodies or rat Minipig liver microsomal FMO1 efficiently catalyzed N-and S-oxygenation reactions; in addition, the minipig liver microsomal FMO1 concentration was higher than the levels in rats, humans, and monkeys. These results suggest that liver microsomal FMO1 could contribute to the relatively high FMO-mediated drug N-and S-oxygenation activities in rat and minipig liver microsomes and that lower expression of FMO1 in human and monkey livers could be a determinant factor for species differences in liver drug N-and S-oxygenation activities between experimental animals and humans.
Introduction
NADPH-dependent flavin-containing monooxygenases (FMO, EC 1.14. 13.8) catalyze the oxygenation of a wide variety of nucleophilic compounds containing nitrogen or sulfur atoms [1, 2] such as diet-derived chemical trimethylamine [3] , anti-cancer agent tozasertib [4] , and dipeptidyl peptidase IV inhibitor teneligliptin [5] . Only human FMO1 to FMO5 are functionally active among eleven human FMO genes identified (FMO1 to FMO11P) [6] . Human FMO3 is considered the prominent functional form expressed in adult human livers and is located in the membranes of the endoplasmic reticulum [7, 8] . Examinations of adult human liver mRNA have revealed high FMO3 expression but low FMO1 expression [9, 10] . In contrast, rat livers have been shown to express moderate levels of FMO1 protein [11] [12] [13] . Recently, we found that after birth, FMO1 and FMO3 in cynomolgus monkey livers were expressed at similar levels to FMO1 and FMO3 in human livers [14] . Pig FMO1 is known to be highly active in drug monooxygenations [3] ; however, molecular analysis of pig and minipig FMO has not yet been fully reported. Experimental animals such as monkey, rat, and minipig are important species widely used in drug development as human models; however, the detailed characterization and comparison across species of drug oxygenation activities of FMO1 and FMO3 in liver microsomes or recombinantly expressed FMO proteins remain to be elucidated. It is important to compare and clarify both the contents and activities of FMO1 and FMO3 in liver microsomes in animal models.
Herein we report the N-and S-oxygenation activities of liver microsomal enzymes from humans, monkeys, rats, and minipigs with respect to four typical FMO substrates 4 (benzydamine, tozasertib, methimazole, and sulindac sulfide shown in Fig. 1 ) and also the activities of recombinantly expressed FMO1 and FMO3 from the same four species. The specific contents of FMO1 and FMO3 in liver microsomes from humans, monkeys, rats, and minipigs were measured. Low levels of FMO1 expression in human livers could be one of the determinant factors explaining species differences in liver FMO-dependent drug monooxygenation activities.
Materials and Methods

Chemicals and enzymes
Benzydamine hydrochloride, benzydamine N-oxide, methimazole, sulindac sulfoxide, and sulindac sulfide were purchased from Sigma-Aldrich (St. Louis, MO, USA). Tozasertib was purchased from Cayman Chemical (Ann Arbor, MI, USA). Pooled human liver microsomes (H150) were obtained from Corning (Tewksbury, MA, USA). Pooled liver microsomes from three male cynomolgus macaques (2-years of age), five male Wistar rats (7- weeks), and three male minipigs (8-months of age, Microminipig registered as a variety of pig in the Japanese Ministry of Agriculture, Forestry and Fisheries, Fuji Micra Inc, Shizuoka, Japan) were prepared as described previously [14, 15] . The other chemicals and reagents used were obtained in the highest grade commercially available.
Molecular cloning of cDNAs and measurement of expression levels for minipig FMO1
and FMO3
Total RNA from three male minipig livers was extracted using an RNeasy Mini Kit 5 (Qiagen, Valencia, CA, USA) according to the manufacturer's protocols and was used for reverse transcription (RT)-polymerase chain reaction (PCR) and qPCR analysis. This study was approved by the Institutional Animal Care and Use Committee of Showa Pharmaceutical University. RT-PCR was performed as previously described [14, 16] using a pool of total RNAs extracted from three minipig livers and the expression levels of FMO1 and FMO3 were quantified.
Briefly, the RT reaction was performed in a mixture containing 1 µg of total RNA, oligo(dT), and SuperScript III RT reverse transcriptase (Invitrogen, Carlsbad, CA, USA) at 50°C for 1 h according to the manufacturer's instructions. RT products were used as the template for PCR reactions, which were performed using KOD-Plus-Neo DNA polymerase (Toyobo, Osaka, Japan) with a thermal cycler (Applied Biosystems, Foster City, CA, USA) according to the manufacturer's protocols. The thermal cycler conditions were an initial denaturation at 94°C for 2 min and 35 cycles of 98°C for 10 s, 65°C for 30 s, and 68°C for 1 min, followed by a final extension at 68°C for 5 min. The primers used are listed in Table 1 .
The PCR products were cloned into a vector using the Zero Blunt TOPO PCR cloning kit (Invitrogen) according to the manufacturer's instructions. The insert of each clone was sequenced using ABI PRISM BigDye Terminator v3.0 Ready Reaction Cycle Sequencing Kit (Applied Biosystems) with an ABI PRISM 3730 DNA Analyzer (Applied Biosystems). Raw sequence data were analyzed with DNASIS Pro (Hitachi Software, Tokyo, Japan), the Genetyx system (Software Development, Tokyo, Japan), and Sequencher (Gene Codes Corporation, Ann Arbor, MI, USA). For amino acid sequences of human, monkey, minipig, and rat FMOs (FMO1 and FMO3), multiple alignments were performed using the Clustal W program. A homology search was conducted using BLAST (National Center for Biotechnology 6 Information) to compare the similarities of FMO1 or FMO3 amino acid sequences between minipigs and humans. The amino acid sequences used were human FMO1 (NP_665683) and FMO3 (NP_000838), monkey FMO1 (AHH29283) and FMO3 (AHH29287), and rat FMO1 (NP_036924) and FMO3 (NP_445885). The amino acid sequences of minipig FMO1 and FMO3 were deduced from the cDNAs obtained in this study.
Expression levels of FMO1 and FMO3 in three minipig livers were quantified by realtime RT-PCR, as described previously [16] . Briefly, RT reactions were carried out as described above using random primers (Invitrogen), one twenty-fifth of which was used for the subsequent PCR. The amplification was performed in a 20-µl reaction using SYBR Green PCR Master Mix (Applied Biosystems) with the ABI PRISM 7500 sequence detection system (Applied Biosystems), according to the manufacturer's protocols. The primers (Table 1) were used at final concentrations of 200 nM. To determine the relative expression levels, the raw data were normalized with the 18S ribosomal RNA level, which was measured using the TaqMan Pre-Developed Assay Reagents for Gene Expression (Applied Biosystems), based on three independent amplifications.
Recombinant human, monkey, rat, and minipig FMO1 and FMO3
Human and rat FMO1 and FMO3 expression plasmids were prepared as described previously [8, 17] . Histidine-tagged monkey FMO1 and FMO3 expression plasmids were prepared as described previously [14] .
Histidine-tagged minipig FMO1 and FMO3 expression plasmids were prepared in this study. PCR was performed as described earlier using the primers listed in Table 1 Membrane preparations expressing FMOs were carried out as described previously [18] . 
Analysis of FMO1-and FMO3-mediated drug oxygenation activities
Rates of N-oxygenation of benzydamine [20] and tozasertib [4] and S-oxygenation of methimazole [21] and sulindac sulfide [22] were determined using liquid chromatography in fluorescence mode or in UV detection mode, as described previously [23] . (KaleidaGraph, Synergy Software, Reading, PA, USA).
Results
Molecular characteristics of minipig FMO1 and FMO3
Because FMO1 has been identified and characterized in the pig [24] , both FMO1 and (Fig. 2) . The minipig FMO3 amino acid sequence had high sequence identity (approximately 83%) with human FMO3; this level of similarity was comparable to that of minipig FMO1, which had 88% sequence identity to human FMO1. Phylogenetic analysis revealed a one-to-one relationship of minipig FMO3 to human, monkey, and rat FMO3; this relationship was similar to that for FMO1 (Fig. 3) . Sequences of minipig FMO1 and FMO3 cDNAs identified in this study have been deposited in GenBank under accession numbers KC734480 and KC734484, respectively.
In minipig livers, both FMO1 and FMO3 genes were expressed, but the expression level of FMO1 was much higher (approximately 16-fold) than that of FMO3. Before quantitation of recombinantly expressed FMO1 and FMO3 proteins in bacterial membranes in this study, the cross-reactivities of four commercially available anti-FMO antibodies were investigated against human, monkey, rat, and minipig FMO1 and FMO3 ( The levels of human and monkey FMO1 proteins in liver microsomes were below the detection limits (<1 pmol FMO per mg protein, Table 3 ). The human and monkey liver microsomal FMO3 contents were 20 and 30 pmol/mg protein, respectively. In contrast, the liver microsomal contents of rat FMO1 and FMO3 were 10 and 120 pmol/mg protein, respectively, and those for minipig FMO1 and FMO3 were 70 and 20 pmol/mg protein, respectively (Table 3) . It was thereby established that human, monkey, and rat liver microsomes had higher contents of FMO3 than FMO1, whereas minipig livers had higher expression of FMO1 than FMO3.
Kinetic parameters for N-and S-oxygenation by liver microsomes
Kinetic parameters for rates of N-oxygenation of benzydamine and tozasertib and Soxygenation of methimazole and sulindac sulfide mediated by liver microsomes from humans, monkeys, rats, and minipigs were determined and analyzed by nonlinear regression ( and S-oxygenations were similar to those for human liver microsomes. These results indicated that highly FMO-dependent N-and S-oxygenation reactions are more likely to occur in rats and minipigs than in humans and monkeys.
Kinetic parameters for N-and S-oxygenation by recombinantly expressed FMO1 and
FMO3
The kinetic parameters for four N-and S-oxygenation reactions mediated by recombinantly expressed human, monkey, rat, and minipig FMO1 and FMO3 were determined (Table 5 
Discussion
In this study, species differences in drug oxygenation activities mediated by FMOs were investigated. Because full-length minipig FMO3 cDNA has not been described to date, in this study, minipig FMO3 and FMO1 cDNAs were isolated and characterized. Sequence analysis revealed that FMO3 contained the amino acid sequence structures characteristic of FMO proteins (Fig. 2) , and phylogenetic analysis showed a one-to-one relationship of minipig FMO3 to human, monkey, and rat FMO3, similar to the relationship for minipig FMO1 (Fig.   3 ). We previously reported that highly FMO-dependent benzydamine N-oxygenation and methyl p-tolyl sulfide S-oxygenation activities in minipig liver microsomes were comparable with those for humans, monkeys, and dogs [15] . The present results revealed that FMO1 was abundantly expressed in minipig liver microsomes (Table 3 and Fig. 3 ), and this abundant 13 minipig FMO1 had high rates of N-oxygenation of benzydamine and tozasertib and Soxygenation of methimazole and sulindac sulfide (Table 5 ). These high FMO1 levels and high catalytic capacities in minipig livers could account for the efficient catalysis of FMOdependent drug monooxygenations in minipig livers (Table 4) . Because the present minipig showed similar P450 [15] and UDP-glucuronosyltransferase [25] activities among other three strains of minipigs (Yucatan, Sinclair, and Gottingen) commercially available, this stain could be representable for one of minipigs in this study.
In rat livers, relatively low levels of rat FMO1 (Table 3 ) with high monooxygenase activities ( Table 5 ) and abundant levels of rat FMO3 with lower activities made different relative contributions to N-oxygenation of benzydamine and tozasertib and S-oxygenation of methimazole and sulindac sulfide (Table 4 ). The relative contribution to overall activity of rat FMO3 in rat liver microsomes were different from those of monkey or human FMO3 in liver microsomes. Recombinant rat FMO1 had relatively low Km values for the substrates with the exception of tozasertib (Table 5 ). Recombinant rat FMO3 appeared to have relatively high Km values for benzydamine. The reason for these differences were not known at present but unknown differences in FMO1/3 anchoring in the membranes and/or larger substrate access channel dependent on the peroxy-flavin might be implied.
Monkey FMOs generally had similar functional characteristics to human FMOs.
Abundant FMO3 (Table 3 [ 14] ) was suggested to be important in drug monooxygenation in cynomolgus macaque livers, just as it is in human livers, although the relationships between the kinetic parameters of monkey FMO1 and FMO3 were slightly different from the predominant metabolic capacity of human FMO3 (Table 5) .
From the viewpoint of the expanding interest in drug interactions mediated by human 14 FMO3, sulindac sulfide S-oxygenation by human liver microsomal FMO3 could be a candidate for a model probe reaction [23, 26] . Because rats and minipigs had higher catalytic capacities for liver microsomal FMO-dependent reactions than humans, the possible contribution of rat or minipig FMO1 might yield results in drug interaction studies that are not applicable to humans. In conclusion, the present results suggest that liver microsomal FMO1 could contribute to drug N-and S-oxygenation activities in liver microsomes from rats and minipigs.
Because of the many similarities between monkeys and humans in terms of FMO expression levels and catalytic activities, monkey FMO3-mediated drug monooxygenation can be considered a good tool for understanding human drug monooxygenases. Low levels of FMO1 expression in human and monkey livers could be key factors explaining the differences between humans/monkeys and rats/minipigs with respect to liver FMO-dependent drug monooxygenase activities. Table 3 . FMO1 and FMO3 expression in liver microsomes from humans, monkeys, rats, and minipigs.
Amount of FMO1 and FMO3 in liver microsomes (5-10 µg protein) from humans, monkeys, rats, and minipigs were immunochemically determined with anti-rat FMO1 peptide antibodies and anti-human FMO3 peptide antibodies, respectively. Table 5 . Kinetic parameters for N-and S-oxygenation reactions mediated by recombinant human, monkey, rat, and minipig FMO enzymes.
Km, µM;
Vmax, min -
Each substrate (0-2000 µM benzydamine, 0-200 µM tozasertib, 0-1000 µM methimazole, and 0-1500 µM sulindac sulfide) was incubated with recombinant FMO (1-50 pmol equivalent) at 37 °C for 10-30 min in the presence of an NADPH-generating system. Kinetic parameters were calculated from a fitted curve by non-linear regression (mean ± SE). 
